| Dr Joseph Ryan Turner, MD | |
|
2880 Dauphin St, Mobile, AL 36606-2457 | |
| (251) 473-1900 | |
| (251) 470-8943 |
| Full Name | Dr Joseph Ryan Turner |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 17 Years |
| Location | 2880 Dauphin St, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366603631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 29045 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Management Inc | 6608869342 | 46 |
News Archive
A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the treatment of schizophrenia.
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers.
Forensic genetics is the branch of genetics that, through DNA analysis and comparison, deals with the resolution of legal problems such as paternity tests.
VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 'insulin-dependent' diabetes, through the European Patent Office.
› Verified 5 days ago
| Entity Name | Premier Health Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538154760 PECOS PAC ID: 6608869342 Enrollment ID: O20040407000654 |
News Archive
A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the treatment of schizophrenia.
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers.
Forensic genetics is the branch of genetics that, through DNA analysis and comparison, deals with the resolution of legal problems such as paternity tests.
VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 'insulin-dependent' diabetes, through the European Patent Office.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Ryan Turner, MD 2880 Dauphin St, Mobile, AL 36606-2457 Ph: (251) 473-1900 | Dr Joseph Ryan Turner, MD 2880 Dauphin St, Mobile, AL 36606-2457 Ph: (251) 473-1900 |
News Archive
A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the treatment of schizophrenia.
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers.
Forensic genetics is the branch of genetics that, through DNA analysis and comparison, deals with the resolution of legal problems such as paternity tests.
VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 'insulin-dependent' diabetes, through the European Patent Office.
› Verified 5 days ago
Jeffrey St. John, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 601 Providence Park Dr E, Mobile, AL 36695 Phone: 251-650-2020 Fax: 251-650-1010 | |
Rollins Lynne Tindell Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Richard Joseph Duffey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Valerie Lanette Vick, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Mark Scott Brown, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6576 Airport Blvd Ste B200, Mobile, AL 36608 Phone: 251-650-5437 Fax: 800-689-2131 | |
Matthew Wooley Mosteller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 | |
Andrew Pope Terry, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 |